154 related articles for article (PubMed ID: 37996226)
1. Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.
Matsuoka A; Fujimori M; Koyama T; Sato A; Mori K; Hirata M; Tanabe N; Nakachi K; Kato S; Okamoto H; Ogawa K; Komatsu H; Iwasaku M; Miyaji T; Uchitomi Y
BMJ Open; 2023 Nov; 13(11):e072472. PubMed ID: 37996226
[TBL] [Abstract][Full Text] [Related]
2. Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.
Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P;
Health Psychol; 2022 Jun; 41(6):396-408. PubMed ID: 35604703
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study.
Nishino M; Fujimori M; Koyama T; Hirata M; Tanabe N; Shimizu T; Yamamoto N; Uchitomi Y
PLoS One; 2023; 18(5):e0283968. PubMed ID: 37235572
[TBL] [Abstract][Full Text] [Related]
4. Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Reitsma M; Fox J; Borre PV; Cavanaugh M; Chudnovsky Y; Erlich RL; Gribbin TE; Anhorn R
J Manag Care Spec Pharm; 2019 May; 25(5):601-611. PubMed ID: 30632889
[TBL] [Abstract][Full Text] [Related]
5. ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Mersiades AJ; Solomon BJ; Thomas DM; Lee CK; Cummins MM; Sebastian L; Ballinger ML; Collignon E; Turnbull OM; Yip S; Morton RL; Brown C; Wheeler PJ; Itchins M; Simes RJ; Pavlakis N
Future Oncol; 2024 Mar; 20(7):361-371. PubMed ID: 37767626
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a multicentre, prospective, cohort study to investigate patient satisfaction and quality of life after immediate breast reconstruction in Japan: the SAQLA study.
Saiga M; Hosoya Y; Utsunomiya H; Kuramoto Y; Watanabe S; Tomita K; Aihara Y; Muto M; Hikosaka M; Kawaguchi T; Miyaji T; Yamaguchi T; Zenda S; Goto A; Sakuraba M; Kusano T; Miyabe K; Kuroki T; Yano T; Taminato M; Sekido M; Tsunoda Y; Satake T; Doihara H; Kimata Y
BMJ Open; 2021 Feb; 11(2):e042099. PubMed ID: 33589456
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.
Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM;
Patient Educ Couns; 2022 Jul; 105(7):2206-2216. PubMed ID: 35153126
[TBL] [Abstract][Full Text] [Related]
9. Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan.
Tang W; Hanada K; Motoo Y; Sakamaki H; Oda T; Furuta K; Abutani H; Ito S; Tsutani K
J Med Econ; 2023; 26(1):614-626. PubMed ID: 37073487
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use.
Proudman D; DeVito NC; Belinson S; Allo MA; Morris ED; Signorovitch J; Patel AK
J Med Econ; 2022; 25(1):817-825. PubMed ID: 35593483
[TBL] [Abstract][Full Text] [Related]
11. Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.
Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P
Support Care Cancer; 2022 Oct; 30(10):8201-8210. PubMed ID: 35809119
[TBL] [Abstract][Full Text] [Related]
12. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
13. Trajectories of success and/or distress: protocol for an observational cohort study investigating changing psychological distress among emerging Ecuadorian adults over a year.
Paz C; Osejo-Taco G; Evans C
BMJ Open; 2021 Dec; 11(12):e056361. PubMed ID: 34930747
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal outcome monitoring in patients with chronic gastroduodenal symptoms investigated using the Gastric Alimetry system: study protocol.
Varghese C; Dachs N; Schamberg G; McCool K; Law M; Xu W; Calder S; Foong D; Ho V; Daker C; Andrews CN; Gharibans AA; O'Grady G
BMJ Open; 2023 Nov; 13(11):e074462. PubMed ID: 38011983
[TBL] [Abstract][Full Text] [Related]
15. First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.
Matsubara J; Mukai K; Kondo T; Yoshioka M; Kage H; Oda K; Kudo R; Ikeda S; Ebi H; Muro K; Hayashi R; Tokudome N; Yamamoto N; Muto M
JAMA Netw Open; 2023 Jul; 6(7):e2323336. PubMed ID: 37459099
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
Fukada I; Mori S; Hayashi N; Hosonaga M; Xiaofei W; Yamazaki M; Ueki A; Kiyotani K; Tonooka A; Takeuchi K; Ueno T; Takahashi S
Cancer Sci; 2023 Dec; 114(12):4632-4642. PubMed ID: 37858313
[TBL] [Abstract][Full Text] [Related]
17. Observational non-randomised controlled evaluation of the effectiveness of cancer counselling centres: a study protocol.
Lingens SP; Schilling G; Harms J; Schulz H; Bleich C
BMJ Open; 2019 Dec; 9(12):e032889. PubMed ID: 31806615
[TBL] [Abstract][Full Text] [Related]
18. Existential distress in patients with advanced cancer and their caregivers: study protocol of a longitudinal cohort study.
Philipp R; Kalender A; Härter M; Bokemeyer C; Oechsle K; Koch U; Vehling S
BMJ Open; 2021 Apr; 11(4):e046351. PubMed ID: 33895716
[TBL] [Abstract][Full Text] [Related]
19. An approach for improvement of the accuracy of cancer gene panel testing.
Imoto K; Yamamoto H; Ohkawa C; Shimada N; Ikuzawa R; Takeda H; Ohhara T; Kojima Y; Furuya N; Motoyoshi A; Migita O; Kuga A; Keira T; Wakamatsu H; Sato T; Oike N; Koike J; Yamano Y; Sunakawa Y
Int J Clin Oncol; 2024 May; 29(5):571-581. PubMed ID: 38472663
[TBL] [Abstract][Full Text] [Related]
20. Role of empathy in the outcomes of colorectal cancer: protocol for a population-based study in two areas in France (EMPACOL Project).
Mulliri A; Lelorain S; Bouvier V; Bara S; Gardy J; Grynberg D; Morello R; Alves A; Dejardin O
BMJ Open; 2022 Nov; 12(11):e066559. PubMed ID: 36446452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
